Retatrutide is a new pharmaceutical in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By activating these receptors, Retatrutide controls cravings, {promotesinsulin secretion, and ultimately contributes to significant slimming. While resea